Atlas Trials

Stage IVA Oropharyngeal Squamous Cell Carcinoma

12 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Stage IVA Oropharyngeal Squamous Cell Carcinoma

RecordFirmDate
Ficlatuzumab w/wo Cetuximab in Patients w/Cetuximab-Resistant, Recurrent or Metastatic Head/Neck Squamous Cell Carcinoma (NCT03422536)University of Arizona2017-12-05
Nivolumab, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV Head and Neck Squamous Cell Carcinoma That Can Be Removed by Surgery (NCT03342911)Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University2017-11-13
Durvalumab Before Surgery in Treating Patients With Oral Cavity or Oropharynx Cancer (NCT02827838)Wake Forest University Health Sciences2017-01-01
Stereotactic Body Radiation Therapy in Treating Patients With High Risk Locally Advanced Head and Neck Cancer (NCT02388932)Case Comprehensive Cancer Center2015-03-03
Reduced-Dose Intensity-Modulated Radiation Therapy With or Without Cisplatin in Treating Patients With Advanced Oropharyngeal Cancer (NCT02254278)NRG Oncology2014-10-01
Cisplatin With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer (NCT02196168)National Cancer Institute (NCI)2014-03-01
Radiation Therapy and Docetaxel in Treating Patients With HPV-Related Oropharyngeal Cancer (NCT01932697)Mayo Clinic2013-09-04
Capecitabine and Vorinostat in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer (NCT01267240)National Cancer Institute (NCI)2010-12-01
Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy (NCT01256385)National Cancer Institute (NCI)2010-11-01
Soy Isoflavones in Preventing Head and Neck Cancer Recurrence in Patients With Stage I-IV Head and Neck Cancer Undergoing Surgery (NCT02007200)National Cancer Institute (NCI)2009-07-01

Track Stage IVA Oropharyngeal Squamous Cell Carcinoma automatically

Every clearance here is in the API, with alerts when new ones post.